Key facts
- Kakehashi’s last known valuation is $295.6M (Mar 2023).
- It has raised $219.1M across 1 recorded rounds; the latest was Later Stage VC (Series C) ($70.3M) in Mar 2023.
- Notable investors include Mitsubishi UFJ Capital, Salesforce Ventures, SMBC Venture Capital, J-Startup, DNX Ventures — 27 tracked in total.
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 27 names
- ·Watchlist + deal alerts for Kakehashi
Funding rounds
1 roundsAbout Kakehashi
Developer of a pharmacy experience platform designed to support patient satisfaction and work style reforms in pharmacies. The company's SaaS-based platform streamlines various pharmacy operations by automatically drafting patient records and providing services that can improve the patient experience itself, enabling pharmacies to operate efficiently.
- Industry
- Enterprise Systems (Healthcare)
- Sector
- Healthcare
- HQ
- Tokyo, Japan
- Founded
- 2016
- Employees
- 356
- Website
- kakehashi.life/
- Ownership
- Privately Held (backing)
Kakehashi doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Kakehashi shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Kakehashi in its N-PORT filings yet. We sweep new filings monthly.